155 related articles for article (PubMed ID: 7828164)
1. Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene.
Iwanuma Y; Kato K; Yagita H; Okumura K
Cancer Immunol Immunother; 1995 Jan; 40(1):17-23. PubMed ID: 7828164
[TBL] [Abstract][Full Text] [Related]
2. Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice.
Takada T; Kato K; Yagita H; Hamada H; Okumura K
Clin Exp Metastasis; 1999 Mar; 17(2):125-30. PubMed ID: 10411104
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
4. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
6. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide preconditioning reduces liver metastasis of Colon26 cells by enhancing antitumor activity of natural killer cells and natural killer T cells in murine liver.
Nishikawa M; Kinoshita M; Morimoto Y; Ishikiriyama T; Nakashima M; Nakashima H; Ono T; Seki S; Moriya T; Yamamoto J; Kishi Y
J Gastroenterol Hepatol; 2021 Jul; 36(7):1889-1898. PubMed ID: 33326135
[TBL] [Abstract][Full Text] [Related]
8. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
[TBL] [Abstract][Full Text] [Related]
9. Production of interleukin-2 by EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity.
Visseren MJ; Koot M; van der Voort EI; Gravestein LA; Schoenmakers HJ; Kast WM; Zijlstra M; Melief CJ
J Immunother Emphasis Tumor Immunol; 1994 Feb; 15(2):119-28. PubMed ID: 8136944
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
11. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.
Hirschowitz EA; Naama HA; Evoy D; Lieberman MD; Daly J; Crystal RG
Cancer Gene Ther; 1999; 6(6):491-8. PubMed ID: 10608345
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Whiteside TL; Chikamatsu K; Nagashima S; Okada K
Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835
[TBL] [Abstract][Full Text] [Related]
13. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.
Hefeneider SH; Conlon PJ; Henney CS; Gillis S
J Immunol; 1983 Jan; 130(1):222-7. PubMed ID: 6600178
[TBL] [Abstract][Full Text] [Related]
14. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
[TBL] [Abstract][Full Text] [Related]
15. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.
Yeh KY; Pulaski BA; Woods ML; McAdam AJ; Gaspari AA; Frelinger JG; Lord EM
Cell Immunol; 1995 Oct; 165(2):217-24. PubMed ID: 7553886
[TBL] [Abstract][Full Text] [Related]
16. Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells.
Fujiwara H; Yamauchi N; Sato Y; Sasaki K; Takahashi M; Okamoto T; Sato T; Iyama S; Koshita Y; Hirayama M; Yamagishi H; Niitsu Y
Jpn J Cancer Res; 2000 Dec; 91(12):1296-302. PubMed ID: 11123429
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
Gansbacher B; Zier K; Daniels B; Cronin K; Bannerji R; Gilboa E
J Exp Med; 1990 Oct; 172(4):1217-24. PubMed ID: 2212951
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo.
Moody DB; Robinson JC; Ewing CM; Lazenby AJ; Isaacs WB
Prostate; 1994 May; 24(5):244-51. PubMed ID: 8170837
[TBL] [Abstract][Full Text] [Related]
19. [Immunoprotective effect of IL-2 and B7-1 gene co-transfected liver cancer vaccines on hepatocarcinogenesis in mice].
Ge N; Ye S; Liu Y; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):417-20. PubMed ID: 12502440
[TBL] [Abstract][Full Text] [Related]
20. In vivo activation of murine natural killer cell functions by human recombinant DNA interleukin 2.
Sayers T; Rossiter H; Chung J; Hren A; Armerding D
Immunobiology; 1985 Apr; 169(3):303-18. PubMed ID: 3922876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
